Findings hold promise for developing regenerative therapies for spinal cord injuries and diseases such as multiple sclerosis
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin — a fatty, insulating sheath essential to normal neural conduction.
“Our findings represent an important conceptual advance in stem cell research,” said Wenbin Deng, principal investigator of the study and associate professor at the UC Davis Department of Biochemistry and Molecular Medicine. “We have bioengineered the first generation of myelin-producing cells with superior regenerative capacity.”
The brain is made up predominantly of two cell types: neurons and glial cells. Neurons are regarded as responsible for thought and sensation. Glial cells surround, support and communicate with neurons, helping neurons process and transmit information using electrical and chemical signals. One type of glial cell — the oligodendrocyte — produces a sheath called myelin that provides support and insulation to neurons. Myelin, which has been compared to insulation around electrical wires that helps to prevent short circuits, is essential for normal neural conduction and brain function; well-recognized conditions involving defective myelin development or myelin loss include multiple sclerosis and leukodystrophies.
In this study, the UC Davis team first developed a novel protocol to efficiently induce embryonic stem cells (ESCs) to differentiate into oligodendroglial progenitor cells (OPCs), early cells that normally develop into oligodendrocytes. Although this has been successfully done by other researchers, the UC Davis method results in a purer population of OPCs, according to Deng, with fewer other cell types arising from their technique.
They next compared electrophysiological properties of the derived OPCs to naturally occurring OPCs. They found that unlike natural OPCs, the ESC-derived OPCs lacked sodium ion channels in their cell membranes, making them unable to generate spikes when electrically stimulated. Using a technique called viral transduction, they then introduced DNA that codes for sodium channels into the ESC-derived OPCs. These OPCs then expressed ion channels in their cells and developed the ability to generate spikes.
According to Deng, this is the first time that scientists have successfully generated OPCs with so-called spiking properties. This achievement allowed them to compare the capabilities of spiking cells to non-spiking cells.
In cell culture, they found that only spiking OPCs received electrical input from neurons, and they showed superior capability to mature into oligodendrocytes.
They also transplanted spiking and non-spiking OPCs into the spinal cord and brains of mice that are genetically unable to produce myelin. Both types of OPCs had the capability to mature into oligo-dendrocytes and produce myelin, but those from spiking OPCs produced longer and thicker myelin sheaths around axons.
“We actually developed ‘super cells’ with an even greater capacity to spike than natural cells,” Deng said. “This appears to give them an edge for maturing into oligodendrocytes and producing better myelin.”
It is well known that adult human neural tissue has a poor capacity to regenerate naturally. Although early cells such as OPCs are present, they do not regenerate tissue very effectively when disease or injury strikes.
Deng believes that replacing glial cells with the enhanced spiking OPCs to treat neural injuries and diseases has the potential to be a better strategy than replacing neurons, which tend to be more problematic to work with. Providing the proper structure and environment for neurons to live may be the best approach to regenerate healthy neural tissue. He also notes that many diverse conditions that have not traditionally been considered to be myelin-related diseases – including schizophrenia, epilepsy and amyotrophic lateral sclerosis (ALS) – actually are now recognized to involve defective myelin.
The Latest Bing News on:
Stem cell technology
- Crown Castle International Corp. (CCI) presents at Morgan Stanley European Technology, Media & Telecom Conference - Transcripton November 18, 2020 at 4:38 pm
Crown Castle International Corp. (NYSE:CCI) Morgan Stanley European Technology, Media & Telecom ... having fiber or being able to build small cells and really trying to solve network problems ...
- A more sensitive way to detect circulating tumor cellson November 18, 2020 at 3:44 pm
but these tumor cells are very rare compared with other blood cells, making them difficult to detect. Although some technologies have been developed to identify CTCs in blood, they suffer from limited ...
- T-Cells May Best Antibodies for Detecting Past COVID-19 Infectionon November 18, 2020 at 1:20 pm
A new T-cell test was more effective than the standard antibody tests currently available for detecting previous infections, even in patients who had been asymptomatic, new data suggest.
- Revolutionary CRISPR-based genome editing system treatment destroys cancer cellson November 18, 2020 at 1:15 pm
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer. The ...
- Sandia secures six regional technology transfer awardson November 18, 2020 at 12:50 pm
For responding with innovative solutions during the pandemic, developing solar cell and hydrogen research technology, and creatively working with companies, Sandia National Laboratories won six ...
- Scientists employ new genetic technology in developing COVID-19 vaccineson November 18, 2020 at 12:44 pm
Exciting news from two manufacturers developing a COVID-19 vaccine, using new genetic technology. Instead of injecting bits of the virus, Pfizer and Moderna's mRNA approach sends an instruction manual ...
- Overly reactivated star-shaped cells explain the unpredictability of Alzheimer's diseaseon November 18, 2020 at 12:40 pm
Researchers have demonstrated that the severity of 'reactive astrocytes' is a key indicator for the onset of Alzheimer's disease.
- Asymmetrex Publishes the First Report of Immortal DNA Strands in Human Stem Cellson November 17, 2020 at 11:00 pm
On November 13, stem cell biotechnology company Asymmetrex published a seminal research report confirming the presence of immortal DNA strands in human tissue stem ...
- Is messenger RNA technology in COVID-19 a new tool to success?on November 17, 2020 at 8:45 am
Moderna (NASDAQ:MRNA) on Monday, reported encouraging preliminary results from its mRNA-based COVID-19 vaccine candidate, mRNA-1273.
- Latest Update 2020: What Makes Cancer Stem Cells Market Outperforming Its Substitutes?on November 17, 2020 at 5:43 am
Research Dive :According to a study, Cancer Stem Cells Market by Research Dive, the global market will surpass $1,722.7 million by 2026. Rising number of cancer patients, coupled with the latest ...
The Latest Google Headlines on:
Stem cell technology
The Latest Bing News on:
Regenerative therapies for spinal cord injuries and diseases
- Cellular pathway of genetic heart disease similar to neurodegenerative diseaseon November 18, 2020 at 3:35 pm
"To my knowledge, this overload of protein granules in cells has only previously been seen in the brain or spinal cord, and some very rare skeletal muscle diseases ... science to diagnostic imaging to ...
- Lineage: OPC1, VAC2, And OpRegen Are Making Progress With Several 2020 Catalysts, 48% Upsideon November 18, 2020 at 2:47 pm
Lineage Cell Therapeutics, Inc. is a clinical-stage biotech company focused on developing therapeutics for degenerative retinal diseases, demyelination-related neurological conditions, and ...
- Regenerative Medicine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025on November 18, 2020 at 9:18 am
According to IMARC Group's latest report, titled "Regenerative Medicine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,". Looking forward, IMARC Group expects the ...
- Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14on November 13, 2020 at 12:30 am
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet ...
- FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technologyon November 12, 2020 at 4:21 am
CelluBridge designated Breakthrough Device by U.S. Food and Drug Administration (FDA) Ottawa, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Spiderwort Inc., a Canadian medical device company developing innovative ...
- Worldwide Regenerative Medicine Industry to 2025 - Featuring Allergan, Amgen and Baxter International Among Otherson November 9, 2020 at 12:20 pm
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global regenerative medicine market grew at a CAGR of ...
- Gene Therapy for Regenerating Optic Nerve May Provide New Glaucoma Treatmenton November 6, 2020 at 4:00 am
In glaucoma, the optic nerve that connects the eye to the brain is progressively damaged, often in association with elevated pressure inside the eye. Researchers used gene therapy to regenerate ...
- Incurable neurological diseases: Moving toward treatmentson November 6, 2020 at 3:50 am
Immunotherapy therapies alter the immune response by stimulating it or using the body’s own immune cells to treat disease. Over the past few decades ... The researchers examined immune cells in fluids ...
- Newly Discovered Cell Could Reverse Nerve Damage From Stroke, Spinal Injuryon October 26, 2020 at 10:16 am
Mark was diagnosed with ALS two years ago and actively participates in clinical research to find effective treatments for the neurodegenerative disease ... this pro-regenerative neutrophil promotes ...
- Discovery of new cell may be key to treating incurable neurological diseaseson October 26, 2020 at 9:03 am
"This immune cell subset secretes growth factors that enhance the survival of nerve cells following traumatic injury ... regenerative neutrophil promotes repair in the optic nerve and spinal cord ...